Progress and Challenges in Precise Treatment of Tumors With PD-1/PD-L1 Blockade
Author:
Funder
National Natural Science Foundation of China
Publisher
Frontiers Media SA
Subject
Immunology,Immunology and Allergy
Reference91 articles.
1. The blockade of immune checkpoints in cancer immunotherapy;Pardoll;Nat Rev Cancer,2012
2. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation;Freeman;J Exp Med,2000
3. Checkpoint blockade in cancer immunotherapy;Korman;Adv Immunol,2006
4. Innate and adaptive immune cells in the tumor microenvironment;Gajewski;Nat Immunol,2013
5. Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma;Miao;Science,2018
Cited by 84 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A Novel Monoclonal Antibody against PD-1 for the Treatment of Viral Oncogene-Induced Tumors or Other Cancer;Cancers;2024-09-01
2. Insights into therapeutic peptides in the cancer-immunity cycle: Update and challenges;Acta Pharmaceutica Sinica B;2024-09
3. Tumor-specific CXCR6 positive precursor CD8 + T cells mediate tumor control in metastatic melanoma;2024-07-16
4. A high affinity monoclonal antibody against HLA-E-VL9 enhances natural killer cell anti-tumor killing;2024-07-11
5. Depletion of regulatory T cells enhancing the anti-tumor effect of in situ vaccination in solid tumors;Pharmacological Research;2024-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3